Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Blue Square Asset Management LLC

Blue Square Asset Management LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 10,991 shares of the medical equipment provider’s stock after buying an additional 259 shares during the quarter. Intuitive Surgical comprises about 2.9% of Blue Square Asset Management LLC’s holdings, making the stock its 12th largest position. Blue Square Asset Management LLC’s holdings in Intuitive Surgical were worth $5,737,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of ISRG. Mirador Capital Partners LP grew its holdings in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the period. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC lifted its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, Consolidated Planning Corp boosted its holdings in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 42,475 shares of company stock worth $22,070,807 in the last 90 days. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 4.0 %

Shares of NASDAQ:ISRG opened at $584.05 on Friday. The business has a fifty day simple moving average of $547.16 and a 200-day simple moving average of $504.35. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $208.03 billion, a P/E ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ISRG shares. Leerink Partners increased their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Raymond James increased their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.